Literature DB >> 9572189

Stress urinary incontinence due to prescription medications: alpha-blockers and angiotensin converting enzyme inhibitors.

S A Menefee1, R Chesson, L L Wall.   

Abstract

BACKGROUND: Several antihypertensive medications affect lower urinary tract function and may cause urinary incontinence. CASE: A 59-year-old woman on doxazosin mesylate for control of her hypertension presented with stress urinary incontinence. Because this drug is known to cause loss of urethral tone leading to stress incontinence in some patients, she was switched to enalapril maleate, an angiotensin converting enzyme inhibitor. Her incontinence improved on the new medication, but she developed a persistent dry cough that continued to cause episodic stress incontinence. Because a persistent cough is a known side effect of angiotensin converting enzyme inhibitors, her medication was changed to a calcium channel blocker, amlodipine besylate. Her cough resolved, and her stress incontinence was no longer a clinical problem.
CONCLUSION: Gynecologists should be aware of the unexpected side effects of medications on the lower urinary tract.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572189     DOI: 10.1016/s0029-7844(97)00497-3

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  10 in total

1.  The Problem of Polypharmacy in Female Patients with Overactive Bladders - Cross-Sectional Study in a Specialist Outpatient Department.

Authors:  C S Schneidinger; W Umek; B Böhmdorfer
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

2.  An interesting case of an antihypertensive causing post-prostatectomy incontinence.

Authors:  Debashis Sarkar; Manal Kumar
Journal:  BMJ Case Rep       Date:  2015-09-30

3.  Medical conditions, medications, and urinary incontinence. Analysis of a population-based survey.

Authors:  Murray M Finkelstein
Journal:  Can Fam Physician       Date:  2002-01       Impact factor: 3.275

4.  The role of urethral ligation after AUS failure and end stage urethra.

Authors:  Peter J Arnold; Mary E Soyster; Ramzy T Burns; Matthew J Mellon
Journal:  Int Urol Nephrol       Date:  2022-08-01       Impact factor: 2.266

Review 5.  [The medication-induced dysfunction of the urinary bladder].

Authors:  T Schneider; H Rübben; M C Michel
Journal:  Urologe A       Date:  2003-12       Impact factor: 0.639

Review 6.  Drug-induced urinary incontinence.

Authors:  Peter Tsakiris; Matthias Oelke; Martin C Michel
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  Urinary incontinence. Non-surgical management by family physicians.

Authors:  K N Moore; B Saltmarche; A Query
Journal:  Can Fam Physician       Date:  2003-05       Impact factor: 3.275

Review 8.  Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence.

Authors:  Cara Tannenbaum; Kristina Johnell
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

9.  The role of prescription drugs in female overactive bladder syndrome-A population-wide cohort study.

Authors:  Wolfgang Umek; Andreas Gleiss; Barbara Bodner-Adler; Berthold Reichardt; Christoph Rinner; Georg Heinze
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-12-05       Impact factor: 2.890

10.  Prevalence of commonly prescribed medications potentially contributing to urinary symptoms in a cohort of older patients seeking care for incontinence.

Authors:  Mandavi Kashyap; Le Mai Tu; Cara Tannenbaum
Journal:  BMC Geriatr       Date:  2013-06-10       Impact factor: 3.921

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.